Maze Therapeutics, Inc. Common Stock (MAZE) — Working Capital to Net Assets Ratio
Maze Therapeutics, Inc. Common Stock (MAZE) has a Working Capital to Net Assets ratio of 92.2% as of December 2025. Working capital of $327.16 Million (current assets of $349.72 Million minus current liabilities of $22.56 Million) is measured against net assets of $354.97 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See Maze Therapeutics, Inc. Common Stock balance sheet quality to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Maze Therapeutics, Inc. Common Stock Working Capital to Net Assets (2022–2025)
This chart shows how Maze Therapeutics, Inc. Common Stock's Working Capital to Net Assets ratio has evolved across 4 annual periods from 2022 to 2025. As of December 2025, the ratio stands at 92.2%, reflecting working capital of $327.16 Million against net assets of $354.97 Million USD. Check MAZE tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Maze Therapeutics, Inc. Common Stock (2022–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Maze Therapeutics, Inc. Common Stock from 2022 to 2025, covering 4 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Maze Therapeutics, Inc. Common Stock market cap and net worth.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 92.2% | $327.16 Million | $354.97 Million | $349.72 Million | $22.56 Million | ▲ +0.2 pp |
| 2024 | 91.9% | $181.00 Million | $196.90 Million | $201.67 Million | $20.67 Million | ▼ -85.1 pp |
| 2023 | 177.0% | $17.79 Million | $10.05 Million | $34.11 Million | $16.32 Million | ▲ +92.8 pp |
| 2022 | 84.2% | $85.37 Million | $101.44 Million | $106.15 Million | $20.78 Million | — |